Although scavengers of ROS have shown discordant results by either promoting or inhibiting tumor cell growth in vivo [45–48], the specific targeting of NOX2 has been reported to reduce murine tumor growth, albeit with variable efficiency [41, 45–49]. Here, CYBB is linked to neoplasm.